JP2023509214A5 - - Google Patents
Info
- Publication number
- JP2023509214A5 JP2023509214A5 JP2022542268A JP2022542268A JP2023509214A5 JP 2023509214 A5 JP2023509214 A5 JP 2023509214A5 JP 2022542268 A JP2022542268 A JP 2022542268A JP 2022542268 A JP2022542268 A JP 2022542268A JP 2023509214 A5 JP2023509214 A5 JP 2023509214A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence shown
- chain variable
- heavy chain
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020071340 | 2020-01-10 | ||
| CNPCT/CN2020/071340 | 2020-01-10 | ||
| PCT/CN2021/070899 WO2021139776A1 (en) | 2020-01-10 | 2021-01-08 | Anti-tigit antibodies, multispecific antibodies comprising the same and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509214A JP2023509214A (ja) | 2023-03-07 |
| JP2023509214A5 true JP2023509214A5 (https=) | 2024-01-16 |
| JP7840852B2 JP7840852B2 (ja) | 2026-04-06 |
Family
ID=76787748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542268A Active JP7840852B2 (ja) | 2020-01-10 | 2021-01-08 | 抗ｔｉｇｉｔ抗体、それを含む多重特異性抗体及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12415858B2 (https=) |
| EP (1) | EP4087862A4 (https=) |
| JP (1) | JP7840852B2 (https=) |
| KR (1) | KR20220131260A (https=) |
| CN (1) | CN115066431A (https=) |
| BR (1) | BR112022013298A2 (https=) |
| CA (1) | CA3164283A1 (https=) |
| WO (1) | WO2021139776A1 (https=) |
| ZA (1) | ZA202208798B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110818795B (zh) * | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
| TW202216778A (zh) | 2020-07-15 | 2022-05-01 | 美商安進公司 | Ｔｉｇｉｔ及ｃｄ１１２ｒ阻斷 |
| CN115505045A (zh) * | 2021-06-23 | 2022-12-23 | 迈威(上海)生物科技股份有限公司 | 靶向lag-3和pd-l1的新型双特异抗体及其应用 |
| CN120399073A (zh) * | 2021-12-31 | 2025-08-01 | 南京维立志博生物科技股份有限公司 | 一种靶向tigit的单域抗体 |
| WO2024083074A1 (en) * | 2022-10-17 | 2024-04-25 | Beigene, Ltd. | Formulations containing anti-tigit antibody and methods of use thereof |
| WO2025170315A1 (ko) * | 2024-02-05 | 2025-08-14 | 주식회사 트리오어 | 이중 기능 도메인을 포함하는 융합단백질 및 이의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6180663B2 (ja) | 2014-12-23 | 2017-08-16 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｔｉｇｉｔに対する抗体 |
| TWI715587B (zh) * | 2015-05-28 | 2021-01-11 | 美商安可美德藥物股份有限公司 | Ｔｉｇｉｔ結合劑和彼之用途 |
| PE20181046A1 (es) | 2015-09-25 | 2018-07-03 | Genentech Inc | Anticuerpos anti-tigit y metodos de uso |
| CA3003777A1 (en) * | 2015-11-18 | 2017-05-26 | Merck Sharp & Dohme Corp. | Pd1/ctla4 binders |
| RU2769282C2 (ru) | 2016-06-20 | 2022-03-30 | Кимаб Лимитед | Анти-PD-L1 и IL-2 цитокины |
| WO2018128939A1 (en) * | 2017-01-05 | 2018-07-12 | Gensun Biopharma Inc. | Checkpoint regulator antagonists |
| EP3710480A4 (en) | 2017-11-17 | 2021-12-15 | Nanjing Legend Biotech Co., Ltd. | SINGLE-DOMAIN ANTIBODIES AND VARIANTS OF THEM DIRECTED AGAINST PD-L1 |
| CN109966487B (zh) * | 2017-12-28 | 2023-08-25 | 上海复宏汉霖生物制药有限公司 | 一种包含抗pd-l1单克隆抗体的药物配制剂 |
| KR102224556B1 (ko) * | 2018-02-06 | 2021-03-09 | 아이-맵 바이오파마 유에스 리미티드 | Ig 및 itim 도메인을 갖는 t 세포 면역 수용체 (tigit)에 대한 항체 및 이것의 사용 |
| CN110818795B (zh) * | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
-
2021
- 2021-01-08 WO PCT/CN2021/070899 patent/WO2021139776A1/en not_active Ceased
- 2021-01-08 KR KR1020227027448A patent/KR20220131260A/ko active Pending
- 2021-01-08 CA CA3164283A patent/CA3164283A1/en active Pending
- 2021-01-08 CN CN202180008450.3A patent/CN115066431A/zh active Pending
- 2021-01-08 EP EP21738025.2A patent/EP4087862A4/en active Pending
- 2021-01-08 JP JP2022542268A patent/JP7840852B2/ja active Active
- 2021-01-08 BR BR112022013298A patent/BR112022013298A2/pt unknown
-
2022
- 2022-07-08 US US17/811,541 patent/US12415858B2/en active Active
- 2022-08-05 ZA ZA2022/08798A patent/ZA202208798B/en unknown